Montel
Williams Debuts Line of Medical Cannabis Products
San Francisco, CA - April 20, 2017
(Investorideas.com Newswire) On Tuesday April 18, 2017, Lenitiv Scientific LLC
debuts its line of high-quality medical cannabis products for patients, under
the brand name LenitivLabs, in dispensaries across California. Alongside the
debut, media personality Montel Williams, founder of Lenitiv Scientific, will
host the following launch events at Bay Area dispensaries:
- April 18, 7pm to 9pm, at
Caliva (1695 S 7th St, San Jose, CA 95112)
- April 19, 7pm to 9pm, at
Purple Lotus Patient Center (752 Commercial St #20, San Jose, CA 95112)
- April 21, 7pm to 9pm, at
Harvest on Geary (4811 Geary Blvd, San Francisco, CA 94118)
LenitivLabs' line of proprietary
products utilize the latest cannabis manufacturing technologies and research to
deliver the highest quality and consistency to patients. The line includes
cannabis oils that patients can conveniently load into vaporizers as well as a
cannabis infused drink. Patients will feel safe knowing there are no harmful
additives and the products are clearly labeled and packaged in consistent,
standardized doses.
"I'm thrilled to be debuting
LenitivLabs," says founder Montel Williams. "My mission—and the
mission of our entire Lenitiv team—is to ensure that patients like myself have
access to the highest-quality medicine available."
Williams—an award-winning media personality,
decorated former Naval officer, entrepreneur, and wellness advocate—was
diagnosed with Multiple Sclerosis (MS) in 1999 and has used cannabis products
as a medication to manage the disease's symptoms.
"Medical cannabis has allowed me
to live a productive, fruitful life despite having multiple sclerosis,"
says Williams. "Many thousands of others across this country have
experienced the same thing, which is what drove me to launch Lenitiv
Scientific."
Williams is one of the nation's
highest-profile advocates for cannabis law reform and has championed the cause
for the past seventeen years. He has worked to pass medical cannabis
legislation in states such as Pennsylvania, New York, Ohio, New Jersey, and
Connecticut and continues to advocate for reform at the federal level and in
states where medical cannabis laws are not currently in effect. An outspoken
advocate for America's servicemen and women, Williams has led the push for
military veterans to legally access medical cannabis without the threat of
losing benefits.
Beginning in April, LenitivLabs'
product line will be available for patients with a doctor's recommendation at
dispensaries throughout northern and southern California (for a full list of
dispensaries that carry LenitivLabs, please visit the LenitivLabs website) with
plans to expand to other states that allow for the sale of medical cannabis.
Note: Lenitiv Labs, LLC operates in
California as a non-profit mutual benefit corporation. All products are
manufactured in a licensed facility in strict compliance with local and state
laws. These statements have not been evaluated by the FDA and are not intended
to diagnose, treat, or cure any disease.
About Lenitiv
Scientific
Lenitiv Scientific develops
innovative, high quality medical cannabis products for patients. The company
works closely with regulators and provides education for the broader community
on topics such as proper dosage and methods of delivery. Lenitiv Scientific was
founded by Montel Williams and former pharmaceutical executive David Racz, who
serves as CEO. The company's world class advisory board includes Former
Director, Central Intelligence, Ambassador R. James Woolsey; Retired Vice
Admiral Edward M. Straw; former Congressman Wilbert Tauzin, former owner of
General Drug, Basil Falcone; Lindy Snider; and Nancye Miller-Woolsey.
SOURCE LenitivLabs
Marijuana
/ Hemp Stocks
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment